Approval was based on the pivotal Phase 3 CodeBreaK 300 study.

Ravensburg, January 14, 2025: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has ...

BioMed X, an independent biomedical research institute based in Germany, has launched a new collaboration with Daiichi Sankyo Co., Ltd.—marking the start of a new initiative to explore innovative ...

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell ...

Caris Life Sciences, a provider of molecular profiling and artificial intelligence (AI)-driven solutions for cancer treatment ...

The treatment will be stockpiled and available for rapid deployment as part of the SNS CHEMPACK program.

CGMP cytokines now available for Charles River’s Cell Therapy Flex Platform.

Designed to increase throughput, decrease COGS, and reduce batch failures.

Emmes Group, a specialty tech and AI-enabled global contract research organization (CRO), has appointed Germaine Gross as ...

IDT Biologika, a global contract development and manufacturing organization (CDMO), has appointed Federico Pollano as Chief ...

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

Touchlight’s facility in Hampton, UK has received GMP certification, making the CDMO the first synthetic DNA manufacturer ...